Research on Covid-19 Medicine and Vaccine

Coronavirus disease 2019 is an endemic vascular and respiratory disease which is an on-going pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019. Currently, 19 network members engaged in research and development of COVID-19 vaccines, using six principal technology platforms and it is identified in humans. World Health Organization complies with international moderations and mechanisms to distribute vaccines across borders. The use of actual manufacturing, fill-finish and distribution proficiency can support an efficient roll-out of vaccines against COVID-19. A vaccine for an infectious disease has never before been composed in less than several years, and no vaccine exists for preventing a coronavirus infection in humans.

  • Immune system
  • Antigen
  • Antibody-dependent enhancement
  • Virus transmission
  • Clinical research
  • Allergen-hypersensitive

Related Conference of Research on Covid-19 Medicine and Vaccine

April 25-26, 2024

36th Nano Congress for Future Advancements

London, UK
May 16-17, 2024

27th World Nanotechnology Congress

Rome, Italy
October 24-25, 2024

7th International Conference on Nanomedicine and Nanotechnology

Zurich, Switzerland
October 24-25, 2024

11th Global Conference on Smart Materials and Nanotechnology

Zurich, Switzerland
December 02-03, 2024

10th Annual Meet on Nanoscience and Nanotechnology

Prague, Czech Republic

Research on Covid-19 Medicine and Vaccine Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in